Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 501–600 of 1,001
Guo, R., Quan, S., Liu, Y., Wang, J., Huang, Z., Guo, X., Bai, M., Xu, E., Yan, X., & Li, Y. (2024) · Human & Experimental Toxicology · doi:10.1177/09603271241288508 · Cited by 5
“6 Re-active oxygen species (ROS) play a central role in this process, not only cause oxidative stress but also trigger in fl ammatory cascades, exacerbate the neuronal injury and apoptosis.”
Liu, H., Shen, Y., Huang, Z., Jiang, T., Huang, P., Yang, M., Zhang, X.-C., Xu, W., & Ni, G.-X. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149296 · Cited by 7
“This condition triggers metabolic acidosis, inflammation, oxidative stress, excitotoxicity, and cytotoxic edema, resulting in neuronal death (Kuriakose & Xiao, 2020).”
BackgroundHealthy food diversity and the risk of major chronic diseases in the EPIC-Potsdam study
Nickel, D., Jannasch, F., Eroglu, E. I., Kuxhaus, O., & Schulze, M. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-78287-5 · Cited by 6
Yang, Z., Jiang, X., & Gao, J. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125069 · Cited by 5
Chin, S. P., Rahim, E. N. A. A., & Arfuzir, N. N. N. (2025) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-025-01037-y · Cited by 6
“To date, approximately 13.7 million people worldwide are diagnosed with stroke each year (Kuriakose & Xiao 2020).”
InfluentialLi, X., Shang, N.-Y., Liu, M., Sui, S., Tang, J., Lan, J., Kang, Y.-Y., Zhang, B.-D., Wen, Z.-P., Feng, X., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01590-y · Cited by 5
“Ischemic stroke, which is one of the most common forms of stroke, is a great burden for patients, families, and society [2, 3].”
Zhao, H., Bi, Y., Wang, S., Yin, Y., Huang, L., Wang, W., Wang, X., Qi, S., & Gong, Z. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149830 · Cited by 5
“Ischemic stroke (Kuriakose and Xiao, 2020) occurs when there is a reduction or interruption of blood supply to the brain, resulting in hypoxia and ischemia of brain tissues.”
Li, X., Zhang, R., Li, G., Liu, Z., Han, H., & Dong, P. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01707-6 · Cited by 5
“Cerebral infarction (CI) is a neurological disorder caused by arterial or vascular occlusion (Kuriakose and Xiao 2020; Bersano and Gatti 2023).”
Wang, F., Qin, Y., & Li, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1217979 · Cited by 5
Inorganic and metal-based nanoparticles
Paul, G., Gupta, U., Shah, H., Mazahir, F., & Yadav, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00006-x · Cited by 7
Ali, M. R., Shoaib, M. H., Nesar, S., Jamal, M., Gul, S., Shahnaz, S., Nawaz, S., Khan, Q., & Imran, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295208 · Cited by 12
Li, J. (2024) · American Journal of Translational Research · doi:10.62347/vyku6210 · Cited by 5
Alabduljabbar, K. A., Elabd, K., Alsaif, A. A., & Basudan, L. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1569_24 · Cited by 5
“[1,2] Epidemiologically, the 2019 GBD study estimated that ischemic strokes contributed to 62.4% of all new stroke cases, with approximately 7.63 million incidents.”
InfluentialGrigonytė, M., Kraujelytė, A., Januškevičiūtė, E., Šėmys, G., Kriukelytė, O., Kontrimavičiūtė, E., Valevičienė, N., & Jatužis, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189464 · Cited by 5
Ainiyah, N. H., Izzah, S. R., Zahroh, C., Bistara, D. N., & Faizah, I. (2021) · Nurse and Holistic Care · doi:10.33086/nhc.v1i2.2221 · Cited by 5
“If not treated immediately, death cell will occur within a few minutes (Kuriakose & Xiao, 2020).”
BackgroundLaser Speckle Flowmetry for the Prognostic Estimation Study of Permanent Focal Ischemia in Mice
Li, C., Zhou, G., Yang, M., Tang, Q., Zhu, L., & Wang, Y. (2022) · BioMed Research International · doi:10.1155/2022/1729255 · Cited by 5
“A variety of animal models, particularly in rodents, have been developed to investigate the underlying pathophysiological mechanisms and explore therapeutics for ischemic stroke [3, 4].”
Jia, H., Chen, Y., & Liu, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5225 · Cited by 4
“Stroke is a major cause of disability and death worldwide (1).”
Brinholi, F. F., Michelin, A. P., Matsumoto, A. K., Semeão, L. D. O., Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Barbosa, D. S., & Maes, M. H. J. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01232-4 · Cited by 7
Duta, T. F., Tsurayya, G., & Naufal, M. A. (2023) · Narra X · doi:10.52225/narrax.v1i1.73 · Cited by 7
“An explanation for this is the relatively longer neurological sequelae (such as reduced muscle contraction and force generation) experienced by chronic stroke patients as compared to those with acute stroke [37].”
BackgroundGuo, Q., Du, A., Wang, J., Wang, L., Zhu, X., Yue, X., Liao, S., Shi, M., Qu, Q., Cheang, I., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808179 · Cited by 5
“Ischemic stroke commonly arises from a sudden reduction or obstruction of cerebral blood flow; it interrupts the transfer of oxygen and essential nutrients to the brain required to maintain metabolism [3].”
BackgroundBielawski, P., Zhang, I., Correa‐Paz, C., Campos, F., Migliavacca, M., Polo, E., del Pino, P., Pelaz, B., Vivien, D., & Maysinger, D. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00271 · Cited by 6
Efficacy and safety of stem cells in the treatment of ischemic stroke: A meta-analysis
Xiong, Y., Guo, X., Gao, W., Ke, C., Huang, X., Pan, Z., Chen, C., Zheng, H., Hu, W., Zheng, F., et al. (2024) · Medicine · doi:10.1097/md.0000000000037414 · Cited by 4
“[2,4] To date, recombinant tissue plasminogen activator standard intravenous thrombolytic therapy represents the only clinically approved drug therapy for acute cerebral infarction.”
BackgroundSiddig, A., Ahmed, K. A. H. M., Haroun, M. S.-E. H., Abdallah, A., Malekaldar, M., Abbasher, A., Abbasher, M., Abbasher, A. A., & Hussien, A. (2022) · Clinical Case Reports · doi:10.1002/ccr3.6017 · Cited by 5
Efficacy of polyarginine peptides in the treatment of stroke: A systematic review and meta‐analysis
Tahmasbi, F., Neishaboori, A. M., Mardani, M., Toloui, A., Komlakh, K., Azizi, Y., & Yousefifard, M. (2022) · Brain and Behavior · doi:10.1002/brb3.2858 · Cited by 4
Ischemic Stroke: New Insights from Risk Factors, Mechanisms and Outcomes
Venketasubramanian, N. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10120472 · Cited by 5
Yang, L., Du, H., Zhang, X., Zhang, D., Su, X., Qiao, Z., & Gao, B. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10230 · Cited by 8
“Inade-quate circulation of blood, known as ischemia, can have deleterious effects on cerebral tissue, potentially leading to the onset of stroke and dementia [8, 9].”
BackgroundMa, R., Wang, S., Cui, Y., Zhang, H., Chen, X., Xie, J., & Li, Y. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.06.034 · Cited by 5
Sharma, J., Gondalia, S., & Sharma, N. (2025) · Cureus · doi:10.7759/cureus.86464 · Cited by 7
“Key risk factors include age (risk doubles over 55 years), hypertension, diabetes mellitus, dyslipidemia, smoking, physical inactivity, and cardiovascular diseases [2,3].”
Liu, Z., Wang, L., Hou, M., Li, S., Zhang, H., & Li, H. (2025) · BioMedical Engineering OnLine · doi:10.1186/s12938-025-01417-1 · Cited by 4
A pilot comparison of the retention rates of FAST and BEFAST stroke warning-sign mnemonics
Guo, S., & Saver, J. L. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1624800 · Cited by 4
Neuroprotective effects of rutin in ischemic stroke: a review
Pourbagher‐Shahri, A. M., Forouzanfar, F., Saburi, E., & Mahaki, H. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01861-4 · Cited by 4
“…the most effective methods for managing stroke are limited to intravenous thrombolysis using intravenous tissue-type plasminogen activator (tPA); yet, the typical time frame for tPA administration is within 4.5 h following the start of stroke (Thiebaut et al. 2018; Kuriakose and Xiao 2020).”
InfluentialNanomaterials: an overview of current trends and future prospects in neurological disorder treatment
Eshak, D., & Arumugam, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06877-6 · Cited by 4
“5, utilizing adequate oxygen to saturate blood, providing support to the cardiac system when required and treatment of pneumonia for respiratory issues [51, 52].”
A systematic study on key Epigenetic modulators in post-stroke conditions
Parikh, D., & Shah, M. (2024) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2024.06.004 · Cited by 4
Prognostic significance of carotid artery stenosis in anterior circulation ischemic stroke patients
Akl, A. Z. O., Shehata, M., Saber, A. R., Afify, H. E.-D. M., & Eldeen, H. Z. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00895-9 · Cited by 5
Hassan, B. D., Dabas, M. M., Kanemitsu, K., Faran, N., & Abbas, T. (2024) · Cureus · doi:10.7759/cureus.71343 · Cited by 4
Shi, L., Xu, M., & Su, Q. (2024) · Technology and Health Care · doi:10.1177/09287329241296739 · Cited by 4
Stroke survivors’ health literacy is not associated with caregiver burden: a cross-sectional study
Engström, A. H., Lindblom, S., Flink, M., Söderberg, S., von Koch, L., & Ytterberg, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-89523-x · Cited by 5
Mulia, G. J., Anna, N., Wu, J. C.-C., Ma, H., Chiang, Y. H., Ou, J., & Chen, K. (2025) · Cell Transplantation · doi:10.1177/09636897251315121 · Cited by 6
Waseem, M. H., Abideen, Z. U., Waheed, A., Raja, H. A. A., Rasheed, S., Mukhlis, M., Ali, M. A., Khan, M., Alam, U., Tahir, M. F., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70420 · Cited by 4
“Acute ischemic stroke (AIS) is a medical emergency indicated by the sudden disruption of blood flow to a part of the brain, leading to neuronal damage and loss of neurological function (Kuriakose and Xiao 2020).”
Neuroprotective effect of riboflavin kinase on cerebral ischemia injury in rats
Zou, Y., Ruan, M.-H., Xu, F., Fei, L., Liu, W., Chen, S., & Chu, Z.-Y. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01170-0 · Cited by 4
Wei, S.-L., & Chiu, K.-L. (2025) · Obesity Research and Clinical Practice · doi:10.1016/j.orcp.2025.05.003 · Cited by 4
Seid, A., Kuma, A., Belete, Y., & Anegagregn, A. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70160 · Cited by 6
Wang, X., Hou, R., Chen, Z., Wang, X., Malek, M., & Wang, H. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70563 · Cited by 8
“To prevent or treat stroke, various measures can be taken, such as recanalization, thrombolysis, primary prevention, secondary prevention, neuroprotection, and neurorepair (Kuriakose and Xiao 2020; Kinlay 2011).”
Aba, M., Kablan, Y., Özhan, O., Karaca, E., Ulu, A., Ateş, B., Vardı, N., & Parlakpınar, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-23284-5 · Cited by 6
“Approximately 14 million people have stroke and approximately 5.5 million people die each year 1 .”
InfluentialHassanzadeh, A., Rahbarghazi, R., Verdi, J., Mahmoudi, J., Moghadam, M. H., Mousakhani, A., Vousooghi, N., & Karimipour, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05291-9 · Cited by 7
“In addition, neuroinflammatory response, energy failure, lack of homeostasis, acidosis, promotion of intracellular calcium levels, excitotoxicity, free radical-mediated toxicity, and blood–brain barrier (BBB) disintegrity largely contribute to stroke [8–10].”
Exploratory Data Analysis and Machine Learning Algorithms to Classifying Stroke Disease
Riyantoko, P. A., Fahrudin, T. M., Hindrayani, K. M., & Idhom, M. (2021) · IJCONSIST JOURNALS · doi:10.33005/ijconsist.v2i02.49 · Cited by 4
“Stroke was classified as a disease of the blood vessels by International Classification of Disease 11 (ICD-11) was released in 2018 [1].”
MethodBrown, J. D., Sato, R., & Morley, J. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173802 · Cited by 5
Lv, M., Zhu, Q., Li, X., Deng, S., Guo, Y., Mao, J., & Zhang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1071533 · Cited by 4
“However, the mechanisms involved in the stroke process are complex, such as excitotoxicity, calcium overload, oxidative stress, inflammatory and apoptosis (3, 4).”
BackgroundRosell, K. T., Castro-García, F. A., Medina-Saldivar, C., Cruz-Visalaya, S. R., & Otalora, L. F. P. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148636 · Cited by 4
Hidayah, J. H., Prakoso, Y. A., & Widyarini, S. (2023) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2023/11.12.2003.2009 · Cited by 5
Khanam, N., Ghosh, A., & Nath, D. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2358686 · Cited by 7
“The sustained reduction in cerebral blood flow and gradual reperfusion offer a minimally invasive technique with a low mortality rate [4].”
Tan, Y., Sun, X., Qin, F., & Cai, Y. (2024) · Applied Nursing Research · doi:10.1016/j.apnr.2024.151820 · Cited by 4
Current Patient Management for Bacterial Meningitis Simultaneously Affected by Stroke
Wong, S., Gee, A., Bazzi, Y. T., Hamby, M., Zheng, J., Henderson, H., Schaar, M., Mina, C., Kamel, I., Chun, K., et al. (2024) · Cureus · doi:10.7759/cureus.69526 · Cited by 4
“The presence of concurrent neurovascular accidents, such as hemorrhagic and ischemic stroke, significantly reduces the likelihood of recovery [11,13,14].”
BackgroundHatamipour, M., Saremi, H., Kesharwani, P., & Sahebkar, A. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108431 · Cited by 5
Farjana, S., Hossain, M. F., Bari, M. U., Khan, A. H., Hossain, M. A., Ali, M. E., Datta, A., Sabrin, S. M., Sharmin, F., Rashid, H. O., et al. (2025) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2025-002604 · Cited by 4
Alizamir, T., Jouzdani, A. F., Attari, F., Arab, L., Ashaari, Z., Komaki, A., & Hassanzadeh, G. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.04.015 · Cited by 4
“It is the third most significant cause of death in developed countries and accounts for most long-term disabilities (Lakhan et al., 2009; Kuriakose and Xiao, 2020).”
Stroke-related restless leg syndrome in hemorrhagic and ischemic stroke patients
Tinh, D. X., Hung, D. V., Thuan, D. D., Duc, D. P., Duc, D. M., Cuong, N. D., Ha, P. T., Hai, N. D., Thuận, N. Đ., Tuan, T. M., et al. (2025) · SAGE Open Medicine · doi:10.1177/20503121251336900 · Cited by 4
Striatal dopaminergic neurons as a potential target for GDNF based ischemic stroke therapy
Beker, M. Ç., Beker, M., Çağlayan, A. B., Bolat, B., Kılıç, Ü., Köse, G. T., & Kılıç, E. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2108-268 · Cited by 4
“This may be due to the severity of the pathophysiological events in the acute stroke such as intense necrosis, inflammation energy failure and excitotoxicity [27].”
BackgroundGong, Q., Yu, B., Wang, M., Chen, M., Xu, H., & Gao, J.-B. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/4463975 · Cited by 4
RetractedHou, Y., & Li, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6061652 · Cited by 4
“Stroke is subdivided into multiple types such as ischemic, hemorrhagic, and transient ischemic stroke, and the treatment method for each type varies significantly [2, 3].”
BackgroundRetractedShen, Y., Cui, J., Zhang, S., Wang, Y., Wang, J., Su, Y., Xu, D., Liu, Y., Guo, Y., & Bai, W. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.956342 · Cited by 4
“To investigate the underlying mechanisms and therapeutic strategies, various animal stroke models have been developed in past decades (Sommer, 2017; Hermann et al., 2019; Kuriakose and Xiao, 2020).”
BackgroundFokina, E. A., Zakharova, I. O., Bayunova, L. V., Avrova, D. K., Ilyasov, I. O., & Avrova, N. F. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023010040 · Cited by 4
Lesmana, I. P. D., Destarianto, P., Widiawan, B., Suryana, A. L., & Hossain, F. S. (2023) · Physiotherapy Quarterly · doi:10.5114/pq.2024.126951 · Cited by 5
Lin, Y.-N., Sang, P. V., Chiu, V. J.-Y., Kang, J., Liou, T., Ni, P., & Chang, F. (2023) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2023.09.016 · Cited by 4
Muscle Synergy Analysis in Ergometer-Based Gait Recovery Training for Stroke Patients
Miyazaki, Y., Chugo, D., Yokota, S., Muramatsu, S., She, J., Ishiguro, K., & Hashimoto, H. (2023) · Annual Conference of the IEEE Industrial Electronics Society (IECON) · doi:10.1109/iecon51785.2023.10312196 · Cited by 4
“A stroke is a disease in which a blood vessel in the brain is ruptured or clogged, causing the brain to lose the ability to send blood and nerve cells to the brain [1].”
BackgroundMatys-Popielska, K., Popielski, K., Matys, P., & Sibilska-Mroziewicz, A. (2024) · Applied Sciences · doi:10.3390/app14010425 · Cited by 9
Harnessing filamentous phages for enhanced stroke recovery
Li, Y., Yang, K., Kong, D.-C., Li, X.-M., Duan, H.-Y., & Ye, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1343788 · Cited by 4
“Emerging biotechnological therapies such as stem cell, gene, and neurostimulation approaches aim to restore neural cells, facilitating cerebral tissue regeneration and functional recovery (105).”
BackgroundInfluentialImproving the reliability of T 2 measurement in magnetic resonance imagingPreprint
Yang, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.09.598128 · Cited by 5
“Enhanced measurement reliability will promote the utilization of T 2 -fitting based physiological MRI techniques in future pathophysiological studies ( 45, 46 ).”
MethodZhan, M., Zheng, X., Gao, J., Shi, S., Song, W., Yao, M., Sun, L., Fan, X., Zhang, Y., & Liu, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119586 · Cited by 3
Zheng, W., Wu, W., Li, Y., Qin, B., Wang, Y., Zeng, Y., Law, B. Y. K., & Wong, V. K. W. (2025) · Brain Sciences · doi:10.3390/brainsci15030290 · Cited by 3
“IS is defined as the interruption of cerebral arterial blood flow due to various factors, leading to neurological impairments resulting from localized hypoxia and ischemic necrosis in brain tissue [2].”
Research Hotspots and Trends of Virtual Reality Intervention for Stroke: Bibliometric Analysis
Wei, Y., Chen, Y., Ma, R., Qiu, Y., Su, W., Zhang, L., & Gao, Q. (2025) · JMIR Serious Games · doi:10.2196/65993 · Cited by 3
“Stroke is a significant contributor to mortality and morbidity globally, ranking as the leading cause of permanent acquired disability [1].”
Osei, S. K. J., & Danso‐Appiah, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324040 · Cited by 3
“Stroke, a neurological disorder resulting from an abrupt injury to cerebral blood vessels [3] is associated with acute and focal neurological deficits that could impact an individual’s ability to perform physical (motor), and cognitive functions [4].”
Advances in clinical studies of peptide drugs in stroke disease
Huo, Y., Zhang, Z., Dong, S., Du, Y., & Ma, M. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167970 · Cited by 3
Li, Y., Liu, Y., & Xiong, J. (2025) · Brain and Behavior · doi:10.1002/brb3.70683 · Cited by 3
“Improving cerebral ischemic blood circulation promotes neurological function and reduces mortality in stroke patients (Sarfo et al. 2018; Kuriakose and Xiao 2020).”
Acupuncture on Post-Stroke Cognitive Impairment: A Systematic Review of Neuroimaging Studies
Yang, S., Bao, Q.-N., Zhong, W., Wu, K., Zhang, X., Yao, J., Chen, Z., Xu, P., Yin, Z., & Liang, F. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s544389 · Cited by 6
Barone‐Rochette, G., Cochard, L., Billères, M., Herault, L., & Mitrofanis, J. (2025) · Annals of Biomedical Engineering · doi:10.1007/s10439-025-03884-y · Cited by 4
“Only reperfusion intervention with recombinant tissue plasminogen activator, administered within the first few hours, has been considered an effective treatment option in acute stroke [10, 13].”
Wang, Y., Chen, Z., Wei, Y., Bai, L., Hu, C., & Wang, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.170779 · Cited by 3
Zhao, Y., Guo, C., Zhang, D., Wei, X., Jiang, X., & Bi, H. (2025) · Clinical Rehabilitation · doi:10.1177/02692155251394944 · Cited by 4
Nursing-Led Quality Improvement Project Achieves 30-Minute Door-to-Needle Time
Powell, K., Hebb, A. M., & Hackett, C. (2025) · Journal of Emergency Nursing · doi:10.1016/j.jen.2025.10.013 · Cited by 3
Yu, Y., Zou, Y., Yang, M., Li, D., Zhao, J., He, Y., Bai, X., Wu, Y., Yao, F., & Fan, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149821 · Cited by 3
Dual-stiffness nanoparticles for compartment-specific drug delivery in stroke
Liu, H., Zheng, J., Li, Y., Wang, R., Yang, Z., Dong, Y., Sun, Y., Du, Z., Pei, L., Qiu, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70340-3 · Cited by 6
Liu, J., Deng, Q., Wei, S., Cheng, L., Shen, C., Liu, Z., Qiu, Y., Teng, J., Wang, L., & Zhang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790943 · Cited by 6
Targeting Ferroptosis for Cerebral Neuroprotection in Ischemic Stroke: Pathophysiological Insights
Song, C., Tang, S., Huang, Y.-P., Xie, G., & Tang, J.-Y. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s605531 · Cited by 3
“…CoQ10 combination therapy; 145 GPX4 stabilizers ACSL4 Promotes PUFA phospholipid synthesis; 6,7 Enhances lipid peroxidation sensitivity; 17,22,23,26,37 Collaborates with LPCAT3 40,41,122,123 ALOX12/15 upregulation enhances activity; 131 HIF-1 α signaling pathway regulation; 19,20,80…”
Santo, L. H. D. E., Zhang, K., Kitabatake, T. T., Pitta, M. G., Rosa, G. H. D. M., Guirro, E. C. D. O., & de Araújo, J. E. (2024) · Rehabilitation and Sports Medicine · doi:10.56294/ri202469 · Cited by 21
Cognitive Disorders in Post-Stroke Patients
Pratiwi, S. H., Sari, E. A., & Mirwanti, R. (2024) · Majalah Kesehatan Indonesia · doi:10.47679/makein.2024203 · Cited by 4
“Brain function disorders experienced by stroke patients depend on the extent to which parts of the brain experience a lack of oxygen (Kuriakose & Xiao, 2020).”
BackgroundJa’afar, N. L., Mustapha, M., Mohamed, M., & Hashim, S. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.3.5 · Cited by 7
Zheng, W., Yan, H., Tian, D., Li, Y., Wang, L., Lei, Y., Wang, B., Wang, Y., Yang, G., & Wang, X. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111693 · Cited by 5
Mehdizadehfar, E., Sadeghi‐Hokmabadi, E., Taheraghdam, A., Sadeghpour, Y., Khabbaz, A., Hosseinzadeh, N., Mehdizadeh, R., Ala, A., Vahdati, S. S., Jafari-Rouhi, A., et al. (2024) · Archives of Neuroscience · doi:10.5812/ans-147803 · Cited by 5
Khan, F. A., Varma, A. R., Negandhi, P. K., Acharya, S., Kumar, S., & Deolikar, V. (2024) · Cureus · doi:10.7759/cureus.70369 · Cited by 5
“Accounting for up to 30% of ischemic strokes, it often leaves clinicians without a clear path for secondary stroke prevention [2].”
BackgroundXiaoni, Z., Xu, Y., & Ma, R. (2024) · Journal of Medical Biochemistry · doi:10.5937/jomb0-51371 · Cited by 3
“Klju~ne re~i: biohemijski faktori u serumu, rano neuro - lo{ko pogor{anje, normogram model za predikciju ing ischemia and hypoxia in brain tissue and thereby triggering further neurological decline (12).”
Wang, Y., Lv, H.-L., He, M., Wu, P., Li, F., & Wang, Y. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s479131 · Cited by 3
Aderinto, N., Olatunji, G. D., Kokori, E., Ukoaka, B. M., Babalola, A. E., Ogieuhi, I. J., Moradeyo, A. A., Yusuf, I. A., Apampa, O. O., Oluwakorede, A. T., et al. (2024) · Discover Medicine · doi:10.1007/s44337-024-00161-0 · Cited by 3
“The synergistic effect of other rehabilitation methods such as physical therapy and pharmacological intervention should also be explored by later works.”
Stroke Prevention and Treatment: Current State and Future Perspective
Suman, K. H., Tasnim, S., Masud, R. I., & Munir, F. (2024) · Nutritional neurosciences · doi:10.1007/978-981-97-6818-9_5 · Cited by 7
İbişoğlu, Z. Ş., & Kılınç, S. (2025) · Neurorehabilitation · doi:10.1177/10538135241304334 · Cited by 4
“Stroke is de fi ned as sudden neurological deterioration caused by interruption of blood fl ow to the brain (Kuriakose & Xiao, 2020).”
Post-Rehabilitation Challenges and Healthcare Needs of Stroke Survivors in Saudi Arabia
Almosallam, A. (2025) · Journal of Disability Research · doi:10.57197/jdr-2025-0002 · Cited by 3
“Stroke survivors’ quality of life is greatly hindered by their disabilities, emphasizing the need for home modifications and mental health support to improve daily functionality [5, 9, 10].”
Liu, X., Li, H., Zhang, F., Zhang, C., Zhou, M., Liu, Q., & Zeng, G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04966-7 · Cited by 5
“Other therapies, such as blood pressure-lowering treatment, glycemic control, antiplatelet therapy, stem cell therapy, and nerve repair, are alternative therapies for ischemic stroke, but there are significant gaps in the current recognition on ischemic stroke treatment [5].”
Potdar, M. B., Bhamare, R. P., Agrawal, Y. O., & Belgamwar, A. V. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01352-2 · Cited by 4
“Immediately after the onset of stroke, a complex interplay of excitotoxicity, oxidative stress, inflammation, and apoptosis occurs [1].”
Kazmi, S., Farokhi-Sisakht, F., Davoody, S., Bahlakeh, G., Abbaszadeh, F., Rahbarghazi, R., Shekarchi, A. A., & Karimipour, M. (2025) · Molecular Brain · doi:10.1186/s13041-025-01201-1 · Cited by 7
“Despite these features, the mortality rate is higher in males compared to females [4, 5].”
Kauk, O. I., Bondarenko, Y. D., & Kulyk, D. (2025) · Psychiatry Neurology and Medical Psychology · doi:10.26565/2312-5675-2025-29-05 · Cited by 5
Геннадьевна, Д. Е., & Vasiliev, A. S. (2021) · Лечащий врач · doi:10.51793/os.2021.29.67.004 · Cited by 4
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


